(Q38893154)

PubMed publication ID

22871647

7 September 2017

title

Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

Carlos Barea

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

German Gonzalez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

Chloe Deyssard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

Antonio Monge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

Ignacio Aldana

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

7 August 2012

1 reference

PubMed publication ID

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

page(s)

9451-9461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 May 2020

start time

7 August 2012

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Synthesis and antiplasmodial activity of 3-furyl and 3-thienylquinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Oral miltefosine treatment in children with visceral leishmaniasis: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Bioisosterism: a useful strategy for molecular modification and drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Antiplasmodial structure-activity relationship of 3-trifluoromethyl-2-arylcarbonylquinoxaline 1,4-di-N-oxide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Synthesis and structure-activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Trypanocidal properties, structure–activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES17089451

Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide

21 January 2018

1 reference

12 December 2020

Anti-malarial activity of some 7-chloro-2-quinoxalinecarbonitrile-1,4-di-N-oxide derivatives

1 reference

12 December 2020

Antimalarial activity and cytotoxicity of (-)-roemrefidine isolated from the stem bark of Sparattanthelium amazonum.

1 reference

12 December 2020

Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives

1 reference

12 December 2020

10.3390/MOLECULES17089451

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json

13 May 2020

PubMed publication ID

22871647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6268756&resulttype=core&format=json